* Low cost of production and R&D boosts efficiency of Indian pharma companies, leading to competitive exports.
* Indian drug & pharmaceutical exports stood at US$ 24.60 billion in FY22 and US$ 24.44 billion in FY21.
* High economic growth along with increasing penetration of health insurance to push expenditure on healthcare and medicine in India.
* In June 2021, Finance Minister Ms. Nirmala Sitharaman announced an additional outlay of Rs. 197,000 crore (US$ 26,578.3 million) that will be utilised over five years for the pharmaceutical PLI scheme in 13 key sectors such as active pharmaceutical ingredients, drug intermediaries and key starting materials.
* The FDI inflows in the Indian drugs and pharmaceuticals sector reached US$ 19.90 billion between April 2000-June 2022.
Ibef Organic Indian Pavilion BIOFACH2022 July 26th-29th, 2022 | Nurember...
The Tenth Edition of the India Trend Fair, Tokyo, Japan is being organised ...
Introduction India has become the fifth largest economy, joining the &ldqu...
Introduction India is rapidly emerging as the global hub for the fintech i...
Introduction India has witnessed exponential growth and is expected to bec...